caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1932208584

Zahida BhattiMD

Infectious DiseaseErie, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Zahida Bhatti's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
COMMUNITY HEALTH NET127367
UPMC HAMOT50100
Associated Clinical Laboratories
Clinical Laboratory · Erie, PA
48177
Emergycare, Inc
Ambulance Service Provider · Erie, PA
1218
Joshua Rosenberg
Diagnostic Radiology · Las Vegas, NV
1218
WILLIAMS, RICHARD1115
David Strasser
Cardiology · Erie, PA
1117
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
292
Unique beneficiaries
—
Total services
342
Distinct HCPCS
7
Medicare payment
$19K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 346 Infectious Disease providers in PA — above median (cohort median 364).
PRESCRIBING · PART D · 2024
Total Rx claims
1,269
Beneficiaries
—
Total drug cost
$1.0M
Distinct drugs
45
Brand share
27.0%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala144 claims
Atorvastatin Calcium103 claims
Amlodipine Besylate88 claims
Gabapentin62 claims
Lisinopril59 claims
QUALITY · MIPS · 2024
Final MIPS score
81.9
Quality
65.8
Cost
73.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.29%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.